172 related articles for article (PubMed ID: 24766252)
1. Sequential immunohistochemistry: a promising new tool for the pathology laboratory.
van den Brand M; Hoevenaars BM; Sigmans JH; Meijer JW; van Cleef PH; Groenen PJ; Hebeda KM; van Krieken JH
Histopathology; 2014 Nov; 65(5):651-7. PubMed ID: 24766252
[TBL] [Abstract][Full Text] [Related]
2. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
3. [T cell/histiocyte-rich large B cell lymphoma].
Liu DG; Du J; Yu Q
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):377-8. PubMed ID: 16185515
[No Abstract] [Full Text] [Related]
4. Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma.
Cho BB; Kelting SM; Gru AA; LeGallo RD; Pramoonjago P; Goldin TA; Heitz CT; Aguilera NS
Ann Diagn Pathol; 2017 Feb; 26():10-15. PubMed ID: 28038705
[TBL] [Abstract][Full Text] [Related]
5. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.
Churchill HR; Roncador G; Warnke RA; Natkunam Y
Hum Pathol; 2010 Dec; 41(12):1726-34. PubMed ID: 20825974
[TBL] [Abstract][Full Text] [Related]
6. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
Hartmann S; Döring C; Vucic E; Chan FC; Ennishi D; Tousseyn T; de Wolf-Peeters C; Perner S; Wlodarska I; Steidl C; Gascoyne RD; Hansmann ML
Br J Haematol; 2015 May; 169(3):415-22. PubMed ID: 25644177
[TBL] [Abstract][Full Text] [Related]
7. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
8. T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.
Van Loo P; Tousseyn T; Vanhentenrijk V; Dierickx D; Malecka A; Vanden Bempt I; Verhoef G; Delabie J; Marynen P; Matthys P; De Wolf-Peeters C
Haematologica; 2010 Mar; 95(3):440-8. PubMed ID: 19797726
[TBL] [Abstract][Full Text] [Related]
9.
Schuhmacher B; Bein J; Rausch T; Benes V; Tousseyn T; Vornanen M; Ponzoni M; Thurner L; Gascoyne R; Steidl C; Küppers R; Hansmann ML; Hartmann S
Haematologica; 2019 Feb; 104(2):330-337. PubMed ID: 30213827
[TBL] [Abstract][Full Text] [Related]
10. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
[TBL] [Abstract][Full Text] [Related]
11. Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features.
Achten R; Verhoef G; Vanuytsel L; De Wolf-Peeters C
Histopathology; 2002 Jan; 40(1):31-45. PubMed ID: 11903596
[TBL] [Abstract][Full Text] [Related]
12. [T-cell/histiocyte-rich B-cell lymphoma: histology, immunophenotype and differential diagnosis].
Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Luo XL
Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):771-5. PubMed ID: 16545182
[TBL] [Abstract][Full Text] [Related]
13. The utility of IMP3 immunohistochemical staining in differentiating nodular lymphocyte predominant Hodgkin Lymphoma from T-Cell/Histiocyte-Rich large B-Cell lymphoma.
Kosari F; Bakhshi T; Ameli F; Mokhtari M
BMC Cancer; 2022 Dec; 22(1):1359. PubMed ID: 36577979
[TBL] [Abstract][Full Text] [Related]
14. Micronodular T-cell/histiocyte-rich large B-cell lymphoma of the spleen: histology, immunophenotype, and differential diagnosis.
Dogan A; Burke JS; Goteri G; Stitson RN; Wotherspoon AC; Isaacson PG
Am J Surg Pathol; 2003 Jul; 27(7):903-11. PubMed ID: 12826882
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas.
Menter T; Bodmer-Haecki A; Dirnhofer S; Tzankov A
Hum Pathol; 2016 Aug; 54():17-24. PubMed ID: 27045512
[TBL] [Abstract][Full Text] [Related]
16. Morphologic, immunphenotypic and clinical discriminators between T-cell/histiocyte-rich large B-cell lymphoma and lymphocyte-predominant Hodgkin lymphoma.
Mourad WA; Al Thani S; Tbakhi A; Al Omari M; Khafaga Y; Shoukri M; El Weshi A; Al Shabana M; Ezzat A
Hematol Oncol Stem Cell Ther; 2008; 1(1):22-7. PubMed ID: 20063524
[TBL] [Abstract][Full Text] [Related]
17. Refractory nodular lymphocyte predominant Hodgkin lymphoma transformed to T-cell/histiocyte-rich B-cell lymphoma in an adolescent: salvage therapy with allogeneic bone marrow transplantation.
Couronné L; Schneider P; Picquenot JM; Laberge S; Bastard C; Vannier JP
J Pediatr Hematol Oncol; 2008 Dec; 30(12):959-62. PubMed ID: 19131792
[TBL] [Abstract][Full Text] [Related]
18. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
19. [Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma].
Kovrigina AM; Probatova NA
Arkh Patol; 2005; 67(4):10-6. PubMed ID: 16209291
[TBL] [Abstract][Full Text] [Related]
20. A Review of the Flow Cytometric Findings in Classic Hodgkin Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte-Rich Large B Cell Lymphoma.
Ally F; Gajzer D; Fromm JR
Clin Lab Med; 2023 Sep; 43(3):427-444. PubMed ID: 37481321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]